- Home
- AGIO vs PLUS Comparison
AGIO vs PLUS Comparison
Compare AGIO & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- PLUS
- Stock Information
- Founded
- AGIO 2007
- PLUS 1990
- Country
- AGIO United States
- PLUS United States
- Employees
- AGIO N/A
- PLUS N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- PLUS Retail: Computer Software & Peripheral Equipment
- Sector
- AGIO Health Care
- PLUS Technology
- Exchange
- AGIO Nasdaq
- PLUS Nasdaq
- Market Cap
- AGIO 2.0B
- PLUS 2.0B
- IPO Year
- AGIO 2013
- PLUS 1996
- Fundamental
- Price
- AGIO $33.23
- PLUS $82.23
- Analyst Decision
- AGIO Buy
- PLUS Hold
- Analyst Count
- AGIO 7
- PLUS 1
- Target Price
- AGIO $56.33
- PLUS $90.00
- AVG Volume (30 Days)
- AGIO 975.9K
- PLUS 201.9K
- Earning Date
- AGIO 02-13-2025
- PLUS 02-04-2025
- Dividend Yield
- AGIO N/A
- PLUS N/A
- EPS Growth
- AGIO N/A
- PLUS N/A
- EPS
- AGIO 11.80
- PLUS 4.03
- Revenue
- AGIO $32,871,000.00
- PLUS $2,123,226,000.00
- Revenue This Year
- AGIO $33.41
- PLUS $1.87
- Revenue Next Year
- AGIO $172.14
- PLUS $5.96
- P/E Ratio
- AGIO $2.78
- PLUS $19.86
- Revenue Growth
- AGIO 36.79
- PLUS N/A
- 52 Week Low
- AGIO $21.18
- PLUS $56.33
- 52 Week High
- AGIO $62.58
- PLUS $106.98
- Technical
- Relative Strength Index (RSI)
- AGIO 36.88
- PLUS 67.97
- Support Level
- AGIO $31.39
- PLUS $73.59
- Resistance Level
- AGIO $35.03
- PLUS $76.49
- Average True Range (ATR)
- AGIO 1.71
- PLUS 2.02
- MACD
- AGIO 0.54
- PLUS 1.19
- Stochastic Oscillator
- AGIO 39.91
- PLUS 98.22
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
About PLUS ePlus inc.
ePlus Inc is a holding company. ePlus through its subsidiaries provides information technology solutions. The company's technology solutions enable organizations to optimize their IT environment and supply chain processes. It also provides consulting, professional and managed services, and complete lifecycle management services including flexible financing solutions. ePlus focuses on selling to medium and large enterprises in the United States and to customers in select international markets including the United Kingdom, the European Union, India, Singapore and Israel.